Zymeworks Announces Antibody Fc Engineering Collaboration and License ... Business Wire (press release) Under the terms of the agreement, Zymeworks and GSK will collaborate to further develop Zymeworks' Effector Function Enhancement and Control Technology (EFECT™) platform through the design, engineering, and testing of novel engineered Fc domains ... |